Literature DB >> 11292696

In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection.

N W Gunther1, V Lockatell, D E Johnson, H L Mobley.   

Abstract

Escherichia coli is the primary cause of uncomplicated infections of the urinary tract including cystitis. More serious infections, characterized as acute pyelonephritis, can also develop. Type 1 fimbriae of E. coli contribute to virulence in the urinary tract; however, only recently has the expression of the type 1 fimbriae been investigated in vivo using molecular techniques. Transcription of type 1 fimbrial genes is controlled by a promoter that resides on a 314-bp invertible element capable of two orientations. One places the promoter in the ON orientation, allowing for transcription; the other places the promoter in the OFF orientation, preventing transcription. A PCR-based assay was developed to measure the orientation of the invertible element during an experimental urinary tract infection in mice. Using this assay, it was found that the percentage of the population ON in urine samples correlated with the respective CFU per gram of bladder (P = 0.0006) but not with CFU per gram of kidney (P > 0.069). Cystitis isolates present in the urine of mice during the course of infection had a higher percentage of their invertible elements in the ON orientation than did pyelonephritis isolates (85 and 34%, respectively, at 24 h; P < 0.0001). In general, cystitis isolates, unlike pyelonephritis isolates, were more likely to maintain their invertible elements in the ON orientation for the entire period of infection. E. coli cells expressing type 1 fimbriae, expelled in urine, were shown by scanning electron microscopy to be densely packed on the surface of uroepithelial cells. These results suggest that expression of type 1 fimbriae is more critical for cystitis strains than for pyelonephritis strains in the early stages of an infection during bladder colonization.

Entities:  

Mesh:

Year:  2001        PMID: 11292696      PMCID: PMC98232          DOI: 10.1128/IAI.69.5.2838-2846.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.

Authors:  B Stentebjerg-Olesen; T Chakraborty; P Klemm
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

Review 2.  Bacterial adhesins: common themes and variations in architecture and assembly.

Authors:  G E Soto; S J Hultgren
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

3.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli.

Authors:  B R Keith; L Maurer; P A Spears; P E Orndorff
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli.

Authors:  J M Abraham; C S Freitag; J R Clements; B I Eisenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

6.  The nationwide nosocomial infection rate. A new need for vital statistics.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

7.  A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.

Authors:  J W Warren; E H Miller; B Fitzpatrick; D E DiFranco; E S Caplan; J H Tenney; W C Anthony
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

8.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice.

Authors:  A J Schaeffer; W R Schwan; S J Hultgren; J L Duncan
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

10.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli.

Authors:  P Klemm
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

View more
  36 in total

1.  Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli.

Authors:  William R Schwan; Jeffrey L Lee; Farrah A Lenard; Brian T Matthews; Michael T Beck
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Transurethral induction of mouse urinary tract infection.

Authors:  Kim H Thai; Anuradha Thathireddy; Michael H Hsieh
Journal:  J Vis Exp       Date:  2010-08-05       Impact factor: 1.355

4.  Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

Authors:  Lana Dbeibo; Julia J van Rensburg; Sara N Smith; Kate R Fortney; Dharanesh Gangaiah; Hongyu Gao; Juan Marzoa; Yunlong Liu; Harry L T Mobley; Stanley M Spinola
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

5.  Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection.

Authors:  Xin Li; Hui Zhao; C Virginia Lockatell; Cinthia B Drachenberg; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women.

Authors:  James R Johnson; Krista Owens; Abby Gajewski; Michael A Kuskowski
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 7.  Virulence and Fitness Determinants of Uropathogenic Escherichia coli.

Authors:  Sargurunathan Subashchandrabose; Harry L T Mobley
Journal:  Microbiol Spectr       Date:  2015-08

Review 8.  Antimicrobial mechanisms of the urinary tract.

Authors:  Milan Chromek; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2007-09-06       Impact factor: 4.599

9.  Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.

Authors:  Mélanie A M Cortes; Julien Gibon; Nathalie K Chanteloup; Maryvonne Moulin-Schouleur; Philippe Gilot; Pierre Germon
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

10.  A murine model of urinary tract infection.

Authors:  Chia-Suei Hung; Karen W Dodson; Scott J Hultgren
Journal:  Nat Protoc       Date:  2009-07-30       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.